The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

Liam Handley, 36, tragically passed away from lung cancer after being misdiagnosed with anxiety. Doctors dismissed his chest ...

Betta noted that Ensacove marks the first innovative targeted lung cancer drug developed by a Chinese ... which was cleared ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced deaths from five common cancers more than any advances in treatments, ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Presurgical camrelizumab plus chemotherapy significantly improved responses versus chemotherapy alone in early or locally ...